| |
 |
|
Class Information
Number: 514/23
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Carbohydrate (i.e., saccharide radical containing) doai
Description: Subject matter wherein the organic active ingredient is a saccharide or polysaccharide, the monomeric saccharide radical units of which contain at least five carbon atoms, or their reaction products wherein the carbon skeleton of the saccharide or polysaccharide of the unit is not destroyed.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618951 |
Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type II diabetes |
Nov. 17, 2009 |
| 7615536 |
1,4-benzothiazepine 1,1-dioxide derivative, process for its preparation, medicaments comprising this compound, and use thereof as a hypolipidaemic |
Nov. 10, 2009 |
| 7601705 |
Polymer controlled induced viscosity fiber system and uses thereof |
Oct. 13, 2009 |
| 7601370 |
Method for controlling body weight in estrogen-insufficient women |
Oct. 13, 2009 |
| 7601364 |
Carbohydrate mixtures |
Oct. 13, 2009 |
| 7598286 |
[(1H-indazol-3-yl)methyl]phenols and (hydroxyphenyl)(1H-indazol-3-yl)methanones |
Oct. 6, 2009 |
| 7592327 |
Asthma/allergy therapy that targets T-lymphocytes and/or eosinophils |
Sep. 22, 2009 |
| 7592306 |
Lactoferrin as an agent in the prevention of organ transplant rejection and graft-versus-host-disease |
Sep. 22, 2009 |
| 7585896 |
Composition for the prevention and treatment of kidney dysfunctions and diseases |
Sep. 8, 2009 |
| 7585510 |
Vaccine |
Sep. 8, 2009 |
| 7579389 |
Antimicrobial acrylic polymer |
Aug. 25, 2009 |
| 7576132 |
Arginine silicate inositol complex and use thereof |
Aug. 18, 2009 |
| 7572764 |
Uses of chemically-modified cholinesterases for detoxification of organophosporus compounds |
Aug. 11, 2009 |
| 7569557 |
Compositions of estrogen-cyclodextrin complexes |
Aug. 4, 2009 |
| 7569540 |
Method for enhanced parenteral nutrition |
Aug. 4, 2009 |
| 7566699 |
Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
Jul. 28, 2009 |
| 7566463 |
Oral rehydration compositions |
Jul. 28, 2009 |
| RE40849 |
Method of treatment of glutathione deficient mammals |
Jul. 14, 2009 |
| 7560443 |
Mixtures of fructose, sucrose and lactose as a low-calorie bulk sweetener with reduced glycemic index |
Jul. 14, 2009 |
| 7560434 |
AZA nucleosides, preparation thereof and use as inhibitors of RNA viral polymerases |
Jul. 14, 2009 |
| 7557089 |
Use of derivatives of succinate esters for the treatment of dementia |
Jul. 7, 2009 |
| 7553819 |
Multivalent inhibitors of serum amyloid P component |
Jun. 30, 2009 |
| 7553818 |
Combination therapy for effecting weight loss and treating obesity |
Jun. 30, 2009 |
| 7553817 |
Methods for improving cardiac function |
Jun. 30, 2009 |
| 7553482 |
Use of a phosphate adsorbent to combat vascular diseases |
Jun. 30, 2009 |
| 7553479 |
Heat stable colloidal iron oxides coated with reduced carbohydrates and uses thereof |
Jun. 30, 2009 |
| 7544671 |
Stabilized hyaluronan preparations and related methods |
Jun. 9, 2009 |
| 7544667 |
Hypocholesterolemic compounds |
Jun. 9, 2009 |
| 7534767 |
C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase |
May. 19, 2009 |
| 7534766 |
Glucuronide metabolites and epimers thereof of tigecycline |
May. 19, 2009 |
| 7531503 |
Cell scaffold matrices with incorporated therapeutic agents |
May. 12, 2009 |
| 7528114 |
C-linked glucuronide of N-(4-hydroxybenzyl) retinone, analogs thereof, and method of using the same to inhibit neoplastic cell growth |
May. 5, 2009 |
| 7528113 |
Method and composition for the treatment of adenoviral ocular infections |
May. 5, 2009 |
| 7524821 |
Scaffolded maleimide clusters for multivalent peptide assembly |
Apr. 28, 2009 |
| 7524513 |
Biofunctional fibers |
Apr. 28, 2009 |
| 7521434 |
Cross-linked gels of hyaluronic acid with hydrophobic polymers and processes for making them |
Apr. 21, 2009 |
| 7521068 |
Dry powder aerosols of nanoparticulate drugs |
Apr. 21, 2009 |
| 7517858 |
Prodrugs of pharmaceuticals with improved bioavailability |
Apr. 14, 2009 |
| 7514410 |
Hepatitis C therapies |
Apr. 7, 2009 |
| 7511095 |
Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith |
Mar. 31, 2009 |
| 7511026 |
Therapeutic agent for nerve damage |
Mar. 31, 2009 |
| 7511022 |
Substituted indole-O-glucosides |
Mar. 31, 2009 |
| 7511021 |
Substituted indazole-O-glucosides |
Mar. 31, 2009 |
| 7511020 |
Substituted benzimidazole-, benztriazole-, and benzimidazolone-O-glucosides |
Mar. 31, 2009 |
| 7510717 |
Non-toxic mutants of pathogenic gram-negative bacteria |
Mar. 31, 2009 |
| 7501399 |
Immunoeffector compounds |
Mar. 10, 2009 |
| 7498311 |
Treatment of migraine |
Mar. 3, 2009 |
| 7491709 |
Treatment with hyaluronic acid |
Feb. 17, 2009 |
| 7482330 |
Substituted fused heterocyclic C-glycosides |
Jan. 27, 2009 |
| 7479493 |
Substituted benzyl amine compounds |
Jan. 20, 2009 |
|
|
|
